Criteria for access to remdesivir – based on global expanded access program

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
25 June 2020
Last updated: 
6 July 2020
Publication type: 
Fact Sheet
Intended audience: 
Health sector

This information sheet includes eligibility criteria for access to remdesivir, which reflects the trial evidence:

  • inclusion criteria
  • exclusion criteria